LC
ASLN

Lindbrook Capital’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Lindbrook Capital’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-125
Closed -$17K – 2018
2021
Q1 		$17K Buy
+125
New +$15.8K ﹤0.01% 822

Other funds holding ASLN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Lindbrook Capital's ASLN Position: Q2 2021 in Review

Lindbrook Capital sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q2 2021, closing a stake of 125 shares — an estimated $17K sold.

Lindbrook Capital first reported a position in ASLN in Q1 2021 and held it in 1 quarter. The position peaked at $17K in Q1 2021. 31 funds tracked by Wall St. Rank hold ASLN as of Q2 2021.

  • Lindbrook Capital reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Lindbrook Capital sold 125 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q2 2021, an estimated $17K.
  • Lindbrook Capital first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 1 quarter.
  • Lindbrook Capital's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $17K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q2 2021.

Based on Lindbrook Capital's 13F filing for Q2 2021, filed 27 Jul 2021.